S-Adenosylmethionine (Same) And Silybin

Verify with FDA CVM →

16 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
16
Total Reports
1
Deaths Reported
620.0%
Death Rate

Active Ingredients

S-Adenosylmethionine (Same) And Silybin

Administration Routes

OralUnknown

Species Affected

Dog 16

Most Affected Breeds

Retriever - Labrador 2
Dachshund - Standard Wire-haired 2
Havanese 2
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1
Crossbred Canine/dog 1
Terrier (unspecified) 1
Terrier - Boston 1
Dachshund - Miniature 1
American Pit Bull Terrier 1
Retriever - Golden 1

Most Reported Reactions

Elevated alanine aminotransferase (ALT) 4
Diarrhoea 3
Wobbliness 3
Elevated serum alkaline phosphatase (ALP) 3
Hypoadrenocorticism 2
Weight loss 2
Elevated serum alkaline phosphatase (SAP) 2
Thrombocytosis 2
Adrenal gland disorder NOS 2
Elevated liver enzymes NOS 2
Hyperkalaemia 2
Hypochloraemia 2

Outcome Breakdown

Outcome Unknown
10 (62.5%)
Recovered/Normal
3 (18.8%)
Ongoing
2 (12.5%)
Euthanized
1 (6.3%)

Data Summary

Metric Value
Total adverse event reports 16
Reports involving death 1
Case-fatality rate (reported events) 620.0%
Distinct species in reports 1
Distinct breeds in reports 13
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

S-Adenosylmethionine (Same) And Silybin Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 16 adverse event reports referencing S-Adenosylmethionine (Same) And Silybin, including 1 reports in which the animal died — a 620.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: S-Adenosylmethionine (Same) And Silybin. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in S-Adenosylmethionine (Same) And Silybin reports are Dog (16 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (2), Dachshund - Standard Wire-haired (2), Havanese (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with S-Adenosylmethionine (Same) And Silybin are Elevated alanine aminotransferase (ALT) (4), Diarrhoea (3), Wobbliness (3), Elevated serum alkaline phosphatase (ALP) (3). Of the 16 reports with a coded outcome, Outcome Unknown is the leading category at 62.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on S-Adenosylmethionine (Same) And Silybin.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial